CPT® Code 90634

1. Indications

The Hepatitis A vaccine (HepA) is indicated for the prevention of hepatitis A virus infection, particularly in pediatric and adolescent populations. The following conditions and circumstances warrant the administration of this vaccine:

• Prevention of Hepatitis A: The primary indication for the HepA vaccine is to provide immunity against hepatitis A, a viral infection that can cause liver inflammation and serious health complications.
• Travel to Endemic Areas: Individuals, especially children and adolescents, who are traveling to regions where hepatitis A is prevalent are advised to receive the vaccine to reduce the risk of infection.
• Close Contact with Infected Individuals: Vaccination is recommended for those who may have close contact with individuals diagnosed with hepatitis A, as this can help prevent the spread of the virus.
• High-Risk Populations: Children and adolescents in high-risk groups, such as those living in areas with poor sanitation or those who are part of communities with higher rates of hepatitis A, should receive the vaccine.

2. Procedure

The administration of the Hepatitis A vaccine (CPT® Code 90634) follows a structured procedure to ensure safety and efficacy. The steps involved in the vaccination process are as follows:

• Step 1: Patient Assessment Before administering the vaccine, healthcare providers should assess the patient's medical history, including any previous allergic reactions to vaccines, current health status, and any contraindications to vaccination.
• Step 2: Preparation of the Vaccine The vaccine should be prepared according to the manufacturer's instructions. This includes checking the expiration date, ensuring proper storage conditions, and gently mixing the vaccine if necessary to ensure uniformity.
• Step 3: Site Selection and Preparation The intramuscular injection site is typically the deltoid muscle in the upper arm for older children and adolescents. The area should be cleaned with an antiseptic wipe to minimize the risk of infection.
• Step 4: Administration of the Vaccine Using a sterile syringe and needle, the vaccine is injected intramuscularly into the selected site. The injection should be administered swiftly and smoothly to minimize discomfort.
• Step 5: Post-Administration Care After the vaccine is administered, the patient should be monitored for a short period to observe for any immediate adverse reactions. The healthcare provider should provide the patient or guardian with information regarding potential side effects and the importance of completing the full vaccination schedule.

3. Post-Procedure

Post-procedure care for the Hepatitis A vaccine involves monitoring the patient for any immediate adverse reactions, which may include mild soreness at the injection site, low-grade fever, or fatigue. Patients should be advised to rest and hydrate adequately following vaccination. It is essential to inform the patient or guardian about the importance of completing the three-dose schedule to ensure optimal immunity. Follow-up appointments should be scheduled to administer the subsequent doses as per the recommended timeline, typically at 1 and 6 months after the initial dose. Additionally, patients should be educated on recognizing any unusual symptoms that may arise post-vaccination and encouraged to seek medical attention if necessary.